Skip to content

Clinical trials

Phase 2 Colorectal Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colorectal Neoplasms Phase: Phase 2 Clear all

1,315 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200017
200131
200226
200324
200436
200532
200646
200744
200845
200958
201040
201150
201248
201336
201443
201541
201633
201738
201856
201966
202047
202153
202265
202375
202466
202592
202658

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed535
Unknown status250
Terminated161
Recruiting160
Active, not recruiting72
Not yet recruiting65
Withdrawn64
Suspended7
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)42
Fudan University41
Sun Yat-sen University36
M.D. Anderson Cancer Center27
Hoffmann-La Roche24
Memorial Sloan Kettering Cancer Center21
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)18
UNICANCER17
Eli Lilly and Company16
Amgen15

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colorectal Neoplasms1,315
Colonic Neoplasms220
Rectal Neoplasms207
Neoplasm Metastasis126
Neoplasms69
Pancreatic Neoplasms47
Breast Neoplasms46
Carcinoma, Non-Small-Cell Lung43
Stomach Neoplasms34
Ovarian Neoplasms29

Trials

Showing 76 to 100 of 1,315. Each trial links to its page on Pharma Observatory.

1,215 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.